J Wave Syndrome: Benign or Malignant?

J Wave Syndrome: Benign or Malignant? Publisher

Sherafati A¹ ; Eslami M¹ ; Mollazadeh R¹

Show Affiliations

1. Department of Cardiology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: ARYA Atherosclerosis Published:2021

Abstract

J wave syndrome is an electrical disease of the heart due to pathologic early repolarization. It encompasses a clinical spectrum from aborted sudden cardiac death due to ventricular arrhythmia (VA) usually in young affected patients to self-terminating ventricular ectopies, and finally, asymptomatic relatives of probands detected during electrocardiography acquisition (early repolarization pattern). This syndrome consists of 2 phenotypes, early repolarization and Brugada syndrome. Herein, we first describe 2 patients with early repolarization and Brugada syndrome, then, discuss their definition, epidemiology, genetics, cellular mechanism, diagnosis, risk stratification, and finally, therapeutic challenges and options one by one in detail. © 2021, Isfahan University of Medical Sciences(IUMS). All rights reserved.

Related Docs

1. Characteristics of Early Repolarization Pattern in the Iranian Population, Iranian Red Crescent Medical Journal (2017)

2. Prevalence and Associated Factors of Ecg Abnormality Patterns Indicative of Cardiac Channelopathies Among Adult General Population of Tehran, Iran: A Report From the Tehran Cohort Study (Tecs), BMC Cardiovascular Disorders (2024)

3. Cardiogenetics: Genetics for Cardiologists, Journal of Knowledge and Health in Basic Medical Sciences (2022)

4. Performance of Electrophysiologic Study in an Asymptomatic Patient With Type 2 Intermittent Brugada Syndrome: To Do or Not to Do, Caspian Journal of Internal Medicine (2018)

5. Transcranial Direct Current Stimulation in Patient With J Wave Syndrome and Implantable Cardioverter Defibrillator, PACE - Pacing and Clinical Electrophysiology (2022)

Experts (# of related papers)

View all Related Experts

Ali Vasheghani Farahani (2)

Reza Mollazadeh (2)

Style	Citing Format
MLA	Sherafati A, Eslami M, Mollazadeh R. "J Wave Syndrome: Benign or Malignant?." ARYA Atherosclerosis, vol. 17, no. 1, 2021, pp. -.
APA	Sherafati A, Eslami M, Mollazadeh R (2021). J Wave Syndrome: Benign or Malignant?. ARYA Atherosclerosis, 17(1), -.
Chicago	Sherafati A, Eslami M, Mollazadeh R. "J Wave Syndrome: Benign or Malignant?." ARYA Atherosclerosis 17, no. 1 (2021): -.
Harvard	Sherafati A, Eslami M, Mollazadeh R (2021) 'J Wave Syndrome: Benign or Malignant?', ARYA Atherosclerosis, 17(1), pp. -.
Vancouver	Sherafati A, Eslami M, Mollazadeh R. J Wave Syndrome: Benign or Malignant?. ARYA Atherosclerosis. 2021;17(1):-.
BibTex	@article{ author = {Sherafati A and Eslami M and Mollazadeh R}, title = {J Wave Syndrome: Benign or Malignant?}, journal = {ARYA Atherosclerosis}, volume = {17}, number = {1}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Sherafati A AU - Eslami M AU - Mollazadeh R TI - J Wave Syndrome: Benign or Malignant? JO - ARYA Atherosclerosis VL - 17 IS - 1 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract